hormonal therapy medicine

Zoplide (Leuprolide Acetate Injection) – Product Description Zoplide contains Leuprolide Acetate, a prescription hormonal therapy medicine used to treat a variety of hormone-dependent cancers and endocrine disorders. It belongs to the gonadotropin-releasing hormone (GnRH) agonist class and works by reducing the production of testosterone in men and estrogen in women. Lowering these hormone levels helps slow the growth of hormone-sensitive cancers and manage certain gynecological and pediatric conditions. Zoplide is administered by a qualified healthcare professional as an injection at intervals determined by the prescribed treatment regimen. It is widely used in oncology and gynecology under specialist supervision. Active Ingredient Leuprolide Acetate Dosage Form Sterile Injection Therapeutic Indications Advanced Prostate Cancer Hormone Receptor-Positive Breast Cancer (selected patients) Endometriosis Uterine Fibroids Central Precocious Puberty (CPP) Other hormone-responsive conditions as recommended by a specialist How It Works Leuprolide Acetate initially stimulates and then suppresses the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This results in a significant reduction in testosterone and estrogen production, helping to slow the growth of hormone-dependent tumors and control disease symptoms. Key Features Effective hormonal therapy for hormone-sensitive cancers Long-acting GnRH agonist for sustained hormone suppression Used in oncology, gynecology, and pediatric endocrinology Administered under specialist medical supervision Manufactured according to stringent pharmaceutical quality standards Storage Store according to the manufacturer's recommendations. Protect from excessive heat and direct light. Keep out of reach of children. Note: Zoplide (Leuprolide Acetate Injection) is a prescription-only medicine and should be administered only under the supervision of a qualified oncologist, gynecologist, or endocrinologist. Regular monitoring of hormone levels and overall clinical response is recommended throughout treatment.